{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:06:23Z","timestamp":1787670383197,"version":"build-2736575974"},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.urolonc.2008.11.001","type":"journal-article","created":{"date-parts":[[2009,3,12]],"date-time":"2009-03-12T04:24:08Z","timestamp":1236831848000},"page":"131-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["The clinical implications of the genetics of renal cell carcinoma"],"prefix":"10.1016","volume":"27","author":[{"given":"Inger","family":"Rosner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennady","family":"Bratslavsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Marston","family":"Linehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2008.11.001_bib1","unstructured":"SEER Cancer Statistics Review, 1975\u20132005. NCI 2007; (November 2007 SEER data submission. Available from URL: http:\/\/seer.cancer.gov\/csr\/1975_2005\/results_merged\/sect_01_overview.pdf and http:\/\/seer.cancer.gov\/csr\/1975_2005\/results_merged\/sect_11_kidney_pelvis.pdf)."},{"key":"10.1016\/j.urolonc.2008.11.001_bib2","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1001\/jama.281.17.1628","article-title":"Rising incidence of renal cell cancer in the United States","volume":"281","author":"Chow","year":"1999","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.urolonc.2008.11.001_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1046\/j.1442-2042.2002.00418.x","article-title":"Recurrence of renal cell carcinoma more than 5 years after nephrectomy","volume":"9","author":"Uchida","year":"2002","journal-title":"Int J Urol"},{"key":"10.1016\/j.urolonc.2008.11.001_bib4","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1097\/01.ju.0000096060.92397.ed","article-title":"The genetic basis of cancer of the kidney","volume":"170","author":"Linehan","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2008.11.001_bib5","doi-asserted-by":"crossref","first-page":"6282S","DOI":"10.1158\/1078-0432.CCR-050013","article-title":"Genetic basis of cancer of the kidney: Disease-specific approaches to therapy","volume":"10","author":"Linehan","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2008.11.001_bib6","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/gcc.2870030404","article-title":"Cytogenetics of renal cell carcinomas associated with von Hippel-Lindau disease","volume":"3","author":"Kovacs","year":"1991","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.urolonc.2008.11.001_bib7","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/327721a0","article-title":"Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma","volume":"327","author":"Zbar","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.urolonc.2008.11.001_bib8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1146\/annurev.ge.20.120186.001311","article-title":"Genetics of human cancer","volume":"20","author":"Knudson","year":"1986","journal-title":"Annu Rev Genet"},{"key":"10.1016\/j.urolonc.2008.11.001_bib9","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/S0022-5347(01)66674-6","article-title":"Prevalence of microscopic lesions in grossly normal renal parenchyma from patients with von Hippel-Lindau disease, sporadic renal cell carcinoma, and no renal disease: Clinical implications","volume":"154","author":"Walther","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2008.11.001_bib10","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/jnci\/81.14.1097","article-title":"Specific genetic change in tumors associated with von Hippel-Lindau disease","volume":"81","author":"Tory","year":"1989","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2008.11.001_bib11","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.8493574","article-title":"Identification of the von Hippel-Lindau disease tumor suppressor gene","volume":"260","author":"Latif","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.urolonc.2008.11.001_bib12","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/(SICI)1098-1004(1998)12:6<417::AID-HUMU8>3.0.CO;2-K","article-title":"Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene","volume":"12","author":"Stolle","year":"1998","journal-title":"Hum Mutat"},{"key":"10.1016\/j.urolonc.2008.11.001_bib13","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/humu.1380050109","article-title":"Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype","volume":"5","author":"Chen","year":"1995","journal-title":"Hum Mutat"},{"key":"10.1016\/j.urolonc.2008.11.001_bib14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/humu.20385","article-title":"Genotype-phenotype correlations in von Hippel-Lindau disease","volume":"28","author":"Ong","year":"2007","journal-title":"Hum Mutat"},{"key":"10.1016\/j.urolonc.2008.11.001_bib15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/ki.1997.3","article-title":"Renal cysts, renal cancer, and von Hippel-Lindau disease","volume":"51","author":"Neumann","year":"1997","journal-title":"Kidney Int"},{"key":"10.1016\/j.urolonc.2008.11.001_bib16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/humu.10302","article-title":"Solid renal tumor severity in von Hippel Lindau disease is related to germline deletion length and location","volume":"23","author":"Maranchie","year":"2004","journal-title":"Hum Mutat"},{"key":"10.1016\/j.urolonc.2008.11.001_bib17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/ng0594-85","article-title":"Mutations of the VHL tumor suppressor gene in renal carcinoma","volume":"7","author":"Gnarra","year":"1994","journal-title":"Nat Gen"},{"key":"10.1016\/j.urolonc.2008.11.001_bib18","first-page":"2852","article-title":"Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas","volume":"54","author":"Shuin","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2008.11.001_bib19","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1126\/science.7660122","article-title":"Inhibition of transcription elongation by the VHL tumor suppressor protein","volume":"269","author":"Duan","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.urolonc.2008.11.001_bib20","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.7660130","article-title":"Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C","volume":"269","author":"Kibel","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.urolonc.2008.11.001_bib21","doi-asserted-by":"crossref","unstructured":"Pause A, Lee S, Worrell RA, et al. The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins. Proc Natl Acad Sci USA 91997;4:2156\u201361.","DOI":"10.1073\/pnas.94.6.2156"},{"key":"10.1016\/j.urolonc.2008.11.001_bib22","doi-asserted-by":"crossref","first-page":"10595","DOI":"10.1073\/pnas.93.20.10595","article-title":"Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein","volume":"93","author":"Iliopoulos","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.urolonc.2008.11.001_bib23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ccr.2004.06.020","article-title":"Dysregulation of HIF and VEGF is a unifying feature of the familial hamartoma syndromes","volume":"6","author":"Brugarolas","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.urolonc.2008.11.001_bib24","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/S0022-5347(05)64156-0","article-title":"Editorial: Kidney Cancer, A Unique Opportunity for the Development of Disease Specific Therapy","volume":"168","author":"Linehan","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2008.11.001_bib25","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0022-5347(17)35015-2","article-title":"Hereditary papillary renal cell carcinoma","volume":"151","author":"Zbar","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2008.11.001_bib26","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/ng0597-68","article-title":"Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas","volume":"16","author":"Schmidt","year":"1997","journal-title":"Nat Gen"},{"key":"10.1016\/j.urolonc.2008.11.001_bib27","first-page":"1719","article-title":"Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene","volume":"58","author":"Schmidt","year":"1998","journal-title":"Cancer Res"},{"issue":"Part 1","key":"10.1016\/j.urolonc.2008.11.001_bib28","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1097\/01.ju.0000139583.63354.e0","article-title":"Early onset hereditary papillary renal carcinoma: Germline missense mutations in the tyrosine kinase domain of the Met proto-oncogene","volume":"172","author":"Schmidt","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2008.11.001_bib29","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/00004728-199709000-00014","article-title":"Imaging features of hereditary papillary renal cancers","volume":"21","author":"Choyke","year":"1997","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.urolonc.2008.11.001_bib30","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1126\/science.1846706","article-title":"Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product","volume":"251","author":"Bottaro","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.urolonc.2008.11.001_bib31","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/jcb.10358","article-title":"HGF\/SF-met signaling in the control of branching morphogenesis and invasion","volume":"88","author":"Zhang","year":"2003","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.urolonc.2008.11.001_bib32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0065-230X(08)60316-4","article-title":"Molecular cytogenetics of renal cell tumors","volume":"62","author":"Kovacs","year":"1993","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.urolonc.2008.11.001_bib33","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/1727","article-title":"Trisomy 7\u2014harboring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas","volume":"20","author":"Zhuang","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.urolonc.2008.11.001_bib34","first-page":"393","article-title":"Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dube syndrome","volume":"11","author":"Zbar","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urolonc.2008.11.001_bib35","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1097\/00000478-200212000-00002","article-title":"Renal tumors in the Birt-Hogg-Dube syndrome","volume":"26","author":"Pavlovich","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2008.11.001_bib36","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1086\/323744","article-title":"Birt-Hogg-Dube syndrome, a genodermatosis associated with spontaneous pneumothorax and kidney neoplasia, maps to chromosome 17p11.2","volume":"69","author":"Schmidt","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1016\/j.urolonc.2008.11.001_bib37","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1535-6108(02)00104-6","article-title":"Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dube syndrome","author":"Nickerson","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.urolonc.2008.11.001_bib38","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1086\/430842","article-title":"Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dube syndrome","volume":"76","author":"Schmidt","year":"2005","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.urolonc.2008.11.001_bib39","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/jnci\/dji154","article-title":"High Frequency of Somatic Frameshift BHD Gene Mutations in Birt-Hogg-Dube-Associated Renal Tumors","volume":"97","author":"Vocke","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2008.11.001_bib40","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1073\/pnas.051633798","article-title":"Inherited Susceptibility to uterine leiomyomas and renal cell cancer","volume":"98","author":"Launonen","year":"2002","journal-title":"Proc Nat. Acad Sci USA"},{"key":"10.1016\/j.urolonc.2008.11.001_bib41","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1097\/PAS.0b013e31804375b8","article-title":"The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome","volume":"31","author":"Merino","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2008.11.001_bib42","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ng849","article-title":"Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata, and papillary renal cell cancer","volume":"30","author":"Tomlinson","year":"2002","journal-title":"Nat Gen"},{"key":"10.1016\/j.urolonc.2008.11.001_bib43","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ccr.2005.06.017","article-title":"HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: Novel role of fumarate in regulation of HIF stability","volume":"8","author":"Isaacs","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.urolonc.2008.11.001_bib44","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1086\/376435","article-title":"Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America","volume":"73","author":"Toro","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.urolonc.2008.11.001_bib45","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/S0022-5347(05)68930-6","article-title":"Renal cancer in families with hereditary renal cancer: Prospective analysis of a tumor size threshold for renal parenchymal sparing surgery","volume":"161","author":"Walther","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2008.11.001_bib46","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/01.ju.0000132127.79974.3f","article-title":"The relationship between renal tumor size and metastases in patients with von Hippel-Lindau Disease","volume":"172","author":"Duffey","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2008.11.001_bib47","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1200\/JCO.2003.02.122","article-title":"Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer","volume":"21","author":"Yang","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2008.11.001_bib48","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa021491","article-title":"A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer","volume":"349","author":"Yang","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2008.11.001_bib49","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1001\/jama.295.21.2516","article-title":"Sunitinib in patients with metastatic renal cell carcinoma","volume":"295","author":"Motzer","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.urolonc.2008.11.001_bib50","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJMoa065044","article-title":"Sunitinib vs. interferon-\u03b1 in metastatic renal-cell carcinoma","volume":"356","author":"Motzer","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2008.11.001_bib51","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1200\/JCO.2005.03.6723","article-title":"Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma","volume":"24","author":"Ratain","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2008.11.001_bib52","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa060655","article-title":"Sorafenib in advanced clear-cell renal-cell carcinoma","volume":"356","author":"Escudier","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2008.11.001_bib53","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/sj.bjc.6603547","article-title":"HIF and fumarate hydratase in renal cancer","volume":"96","author":"Sudarshan","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urolonc.2008.11.001_bib54","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ccr.2004.09.006","article-title":"Focus on kidney cancer","volume":"6","author":"Linehan","year":"2004","journal-title":"Cancer Cell"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143908003256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143908003256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T09:54:37Z","timestamp":1761040477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143908003256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S1078143908003256"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2008.11.001","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The clinical implications of the genetics of renal cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2008.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}